Test Utilization: Payment Policies More Effective than Practice Recommendations in Curbing Orders of Low-Value Tests
...
This content is for Paid Members only.
Register
Register
Already a member? Log in here
FDA Takes Unprecedented Measures to Promote Rapid Development of Coronavirus Diagnostic Tests
...
This content is for Paid Members only.
Register
Register
Already a member? Log in here
ACMG the Latest to Come Out Against Genetic Testing for All Breast Cancer Patients
...
This content is for Paid Members only.
Register
Register
Already a member? Log in here
FDA Watch: Agency Resounds the Alarm on Biotin Test Interference
In early November 2019, the U.S. Food and Drug Administration (FDA) updated a previous safety communication about the potential of biotin to significantly interfere with diagnostic tests. The update reiterates the warning
This content is for Paid Members only.
Register
Register
Already a member? Log in here
Testing Trends: The Debate Continues Over Regular Colorectal Screening for Average Risk Adults
...
This content is for Paid Members only.
Register
Register
Already a member? Log in here